BioNeMo

NVIDIA BioNeMo is a cloud API service and framework for training and deploying foundation models for generative biology and chemistry.

Key Capabilities

• Multi-Modal Generation: BioNeMo hosts a suite of state-of-the-art models for both small molecules (like MegaMolBART) and proteins (like ESM-2, ProtGPT2).
• Accelerated Inference: By leveraging NVIDIA’s optimized infrastructure, BioNeMo allows researchers to generate novel protein sequences or predict protein structures orders of magnitude faster than running models on local, unoptimized hardware.
• Customizable Pipelines: The framework allows pharmaceutical companies to fine-tune these massive foundation models using their own proprietary, highly confidential wet-lab data without exposing that data to the public internet.

Usage in Healthcare

BioNeMo accelerates early-stage drug discovery. Instead of spending months synthesizing and testing thousands of chemical compounds in a laboratory, researchers can use generative AI to design novel molecules that perfectly fit a target protein’s binding pocket, significantly reducing the time and cost required to discover new therapeutics.